Figures & data
Table 1.
Main studies involving metformin and heart failure (HF).
McAlister FA, Eurich DT, Majumdar SR, Johnson JA. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy. Eur J Heart Fail 2008;10:703-8 Tzoulaki I, Molokhia M, Curcin V, Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ 2009;339:b4731 Pantalone KM, Kattan MW, Yu C, The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis. Acta Diabetol 2009;46:145-54 Eurich DT, Majumdar SR, McAlister FA, Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 2005;28:2345-51 Masoudi FA, Inzucchi SE, Wang Y, Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 2005;111:583-90 Inzucchi SE, Masoudi FA, Wang Y, Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care 2005;28:1680-9 Karter AJ, Ahmed AT, Liu J, Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Diabet Med 2005;22:986-93 Eurich DT, McAlister FA, Blackburn DF, Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ 2007;335:497 MacDonald MR, Eurich DT, Majumdar SR, Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care 2010;33:1213-18 Shah DD, Fonarow GC, Horwich TB. Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. J Card Fail 2010;16:200-6 Andersson C, Olesen JB, Hansen PR, Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia 2010;53:2546-53 Roussel R, Travert F, Pasquet B, Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 2010;170:1892-9 Evans JM, Doney AS, AlZadjali MA, Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus. Am J Cardiol 2010;106:1006-10 Aguilar D, Chan W, Bozkurt B, Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail 2011;4:53-8